{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:27:05Z","timestamp":1786120025979,"version":"build-2736575974"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1097\/mjt.0b013e3182204ffe","type":"journal-article","created":{"date-parts":[[2011,7,16]],"date-time":"2011-07-16T10:09:11Z","timestamp":1310810951000},"page":"118-120","source":"Crossref","is-referenced-by-count":13,"title":["Gemcitabine-Associated \u201cPseudocellulitis\u201d and \u201cPseudosepsis\u201d"],"prefix":"10.1097","volume":"20","author":[{"given":"Karam M.","family":"Obeid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anilrudh A.","family":"Venugopal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-18-20210202","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1517\/14796694.1.1.7","article-title":". Role of gemcitabine in cancer therapy.","volume":"1","author":"Toschi","year":"2005","journal-title":"Future Oncol"},{"key":"R2-18-20210202","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/sj.bjc.6602001","article-title":". Phase II study of radiotherapy combined with gemcitabine for locally advanced pancreatic cancer.","volume":"91","author":"Okusaka","year":"2004","journal-title":"Br J Cancer"},{"key":"R3-18-20210202","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1365-2354.2008.01050.x","article-title":"Gemcitabine and carboplatin in the treatment of transitional cell carcinoma of the urothelium: a single centre experience and review of the literature.","volume":"19","author":"Hudson","year":"2010","journal-title":"Eur J Cancer"},{"key":"R4-18-20210202","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1200\/JCO.2006.09.0886","article-title":". Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss group of clinical cancer research and the central European cooperative oncology group.","volume":"25","author":"Herrmann","year":"2007","journal-title":"J Clin Oncol"},{"key":"R5-18-20210202","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/jama.2010.1275","article-title":". Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial.","volume":"304","author":"Neoptolemos","year":"2010","journal-title":"JAMA"},{"key":"R6-18-20210202","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1002\/(SICI)1097-0142(19990315)85:6<1261::AID-CNCR7>3.0.CO;2-T","article-title":". An investigational new drug treatment program for patients with gemcitabine.","volume":"85","author":"Storniolo","year":"1999","journal-title":"Cancer"},{"key":"R7-18-20210202","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/sj.bjc.6600446","article-title":". A double-blind placebo-controlled, randomized study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer.","volume":"87","author":"Bramhall","year":"2002","journal-title":"Br J Cancer"},{"key":"R8-18-20210202","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1200\/JCO.2004.10.112","article-title":". Phase III trial of gemcitabine plus tipifarnib compared with gemcitabine plus placebo in advanced pancreatic cancer.","volume":"22","author":"Van Cutsem","year":"2004","journal-title":"J Clin Oncol"},{"key":"R9-18-20210202","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1200\/JCO.2006.07.9525","article-title":". Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the national cancer institute of Canada clinical trials group.","volume":"25","author":"Moore","year":"2007","journal-title":"J Clin Oncol"},{"key":"R10-18-20210202","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/annonc\/mdg109","article-title":". Treatment of pancreatic cancer with a combination of irinotecan (CPT-11) and gemcitabine: a multicenter phase II study by the Greek cooperative group for pancreatic cancer.","volume":"14","author":"Stathopoulos","year":"2003","journal-title":"Ann Oncol"},{"key":"R11-18-20210202","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00001813-200001000-00003","article-title":". Time- and dose-limiting erysepeloid rash confined to areas of lymphedema following treatment with gemcitabine. A report of three cases.","volume":"11","author":"Brandes","year":"2000","journal-title":"Anti-Cancer Drugs"},{"key":"R13-18-20210202","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1046\/j.1468-3083.2002.00485.x","article-title":". Gemcitabine-induced erysipeloid skin lesions in a patient with malignant mesothelioma.","volume":"16","author":"Kuku","year":"2002","journal-title":"Eur Acad Dermatol Venereol"},{"key":"R14-18-20210202","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1086\/520684","article-title":". Gemcitabine-related pseudocellulitis: report of 2 cases and review of the literature.","volume":"45","author":"Tan","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R15-18-20210202","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ctrv.2005.07.008","article-title":". Radiation recall: a well recognized but neglected phenomenon.","volume":"31","author":"Azria","year":"2005","journal-title":"Cancer Treat Rev"},{"key":"R16-18-20210202","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1002\/cncr.20229","article-title":". Gemcitabine-related radiation recall preferentially involves internal tissue and organs.","volume":"100","author":"Friedlander","year":"2004","journal-title":"Cancer"}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00045391-201301000-00018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:40:12Z","timestamp":1786045212000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00045391-201301000-00018"}},"subtitle":["A case report and Review of the Literature"],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/mjt.0b013e3182204ffe","relation":{},"ISSN":["1075-2765"],"issn-type":[{"value":"1075-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}